TABLE 1.
Properties of viruses used in this study and the effects of DFMO
| Virus | Family | Genus | Sense | Envelope | Segmented | Effect of DFMO (fold reduction in titer)a | Cell type |
|---|---|---|---|---|---|---|---|
| Chikungunya virusb | Togaviridae | Alphavirus | + | Yes | No | 200** | BHK-21 |
| 8* | Murine fibroblasts | ||||||
| 12** | Vero | ||||||
| 12** | Human fibroblasts | ||||||
| 28* | C6/36 | ||||||
| Sindbis virus | Togaviridae | Alphavirus | + | Yes | No | 10*** | BHK-21 |
| MERS coronavirus | Coronaviridae | Coronavirus | + | Yes | No | 30*** | Vero |
| Dengue virus, serotype 1 | Flaviviridae | Flavivirus | + | Yes | No | 60*** | BHK-21 |
| Zika virusb | Flaviviridae | Flavivirus | + | Yes | No | 15*** | BHK-21 |
| Japanese encephalitis virus | Flaviviridae | Flavivirus | + | Yes | No | 5** | BHK-21 |
| Yellow fever virus | Flaviviridae | Flavivirus | + | Yes | No | 90* | BHK-21 |
| Enterovirus A71 | Picornaviridae | Enterovirus | + | No | No | 12* | HeLa |
| Coxsackievirus B3 | Picornaviridae | Enterovirus | + | No | No | 10* | HeLa |
| Poliovirus | Picornaviridae | Enterovirus | + | No | No | 20* | HeLa |
| Rift Valley fever virus | Bunyaviridae | Phlebovirus | − | Yes | Yes | 200*** | BHK-21 |
| Vesicular stomatitis virus | Rhabdoviridae | Vesiculovirus | − | Yes | No | 20** | BHK-21 |
| Rabies virus | Rhabdoviridae | Lyssavirus | − | Yes | No | 2*** | Cortical neurons |
Calculated by dividing titers from untreated cells by titers from DFMO-treated cells. Statistical significance was determined using a one-tailed Student's t test to compare the results for untreated and DFMO-treated cultures. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
As described previously (4).